Tuberin – A New Molecular Target in Alzheimer’s Disease?

By Ferrando-Miguel Rosa   Rosner Margit   Freilinger Angelika   Lubec Gert   Hengstschläger Markus  

Neurochemical Research, Vol. 30, Iss. 11, 2005-11 ,pp. : 1413-1419

Springer Publishing Company

Access to resources Recommend Favorite

Tau as a Drug Target in Alzheimer’s Disease

By Gozes Illana  

Journal of Molecular Neuroscience, Vol. 19, Iss. 3, 2002-12 ,pp. : 337-338

Humana Press, Inc

Access to resources Recommend Favorite

Insulin-degrading enzyme, apolipoprotein E, and Alzheimer’s disease

By Edland Steven  

Journal of Molecular Neuroscience, Vol. 23, Iss. 3, 2004-10 ,pp. : 213-217

Humana Press, Inc

Access to resources Recommend Favorite

Use of angiotensin-converting enzyme inhibitors for Alzheimer’s disease: an update

By O’Caoimh Rónán   Kehoe Patrick Gavin   Kennedy Paul   Molloy William  

Neurodegenerative Disease Management, Vol. 3, Iss. 6, 2013-12 ,pp. : 511-514

Future Medicine

Access to resources Recommend Favorite

Apolipoprotein E-related neurotoxicity as a therapeutic target for Alzheimer’s disease

By Marques Marcos   Crutcher Keith  

Journal of Molecular Neuroscience, Vol. 20, Iss. 3, 2003-08 ,pp. : 327-337

Humana Press, Inc

Access to resources Recommend Favorite